Adenosine receptor containing oligomers: their role in the control of dopamine and glutamate neurotransmission in the brain. 2011

Francisco Ciruela, and Maricel Gómez-Soler, and Diego Guidolin, and Dasiel O Borroto-Escuela, and Luigi F Agnati, and Kjell Fuxe, and Víctor Fernández-Dueñas
Departament de Patologia i Terapèutica Experimental, Universitat de Barcelona, 08097 L'Hospitalet de Llobregat, Spain. fciruela@ub.edu

While the G protein-coupled receptor (GPCR) oligomerization has been questioned during the last fifteen years, the existence of a multi-receptor complex involving direct receptor-receptor interactions, called receptor oligomers, begins to be widely accepted. Eventually, it has been postulated that oligomers constitute a distinct functional form of the GPCRs with essential receptorial features. Also, it has been proven, under certain circumstances, that the GPCR oligomerization phenomenon is crucial for the receptor biosynthesis, maturation, trafficking, plasma membrane diffusion, and pharmacology and signalling. Adenosine receptors are GPCRs that mediate the physiological functions of adenosine and indeed these receptors do also oligomerize. Accordingly, adenosine receptor oligomers may improve the molecular mechanism by which extracellular adenosine signals are transferred to the G proteins in the process of receptor transduction. Importantly, these adenosine receptor-containing oligomers may allow not only the control of the adenosinergic function but also the fine-tuning modulation of other neurotransmitter systems (i.e. dopaminergic and glutamatergic transmission). Overall, we underscore here recent significant developments based on adenosine receptor oligomerization that are essential for acquiring a better understanding of neurotransmission in the central nervous system under normal and pathological conditions.

UI MeSH Term Description Entries
D009435 Synaptic Transmission The communication from a NEURON to a target (neuron, muscle, or secretory cell) across a SYNAPSE. In chemical synaptic transmission, the presynaptic neuron releases a NEUROTRANSMITTER that diffuses across the synaptic cleft and binds to specific synaptic receptors, activating them. The activated receptors modulate specific ion channels and/or second-messenger systems in the postsynaptic cell. In electrical synaptic transmission, electrical signals are communicated as an ionic current flow across ELECTRICAL SYNAPSES. Neural Transmission,Neurotransmission,Transmission, Neural,Transmission, Synaptic
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D004298 Dopamine One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action. Hydroxytyramine,3,4-Dihydroxyphenethylamine,4-(2-Aminoethyl)-1,2-benzenediol,Dopamine Hydrochloride,Intropin,3,4 Dihydroxyphenethylamine,Hydrochloride, Dopamine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015398 Signal Transduction The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Cell Signaling,Receptor-Mediated Signal Transduction,Signal Pathways,Receptor Mediated Signal Transduction,Signal Transduction Pathways,Signal Transduction Systems,Pathway, Signal,Pathway, Signal Transduction,Pathways, Signal,Pathways, Signal Transduction,Receptor-Mediated Signal Transductions,Signal Pathway,Signal Transduction Pathway,Signal Transduction System,Signal Transduction, Receptor-Mediated,Signal Transductions,Signal Transductions, Receptor-Mediated,System, Signal Transduction,Systems, Signal Transduction,Transduction, Signal,Transductions, Signal
D055503 Protein Multimerization The assembly of the QUATERNARY PROTEIN STRUCTURE of multimeric proteins (MULTIPROTEIN COMPLEXES) from their composite PROTEIN SUBUNITS. Protein Dimerization,Protein Heteromultimerizaton,Protein Multimer Assembly,Protein Trimerization,Assembly, Protein Multimer,Dimerization, Protein,Heteromultimerizaton, Protein,Heteromultimerizatons, Protein,Multimer Assembly, Protein,Multimerization, Protein,Trimerization, Protein
D018047 Receptors, Purinergic P1 A class of cell surface receptors that prefer ADENOSINE to other endogenous PURINES. Purinergic P1 receptors are widespread in the body including the cardiovascular, respiratory, immune, and nervous systems. There are at least two pharmacologically distinguishable types (A1 and A2, or Ri and Ra). Adenosine Receptors,P1 Purinoceptors,Purinergic P1 Receptors,Receptors, Adenosine,Adenosine Receptor,P1 Purinoceptor,Receptor, Purinergic P1,P1 Receptor, Purinergic,P1 Receptors, Purinergic,Purinergic P1 Receptor,Purinoceptor, P1,Purinoceptors, P1,Receptor, Adenosine
D018698 Glutamic Acid A non-essential amino acid naturally occurring in the L-form. Glutamic acid is the most common excitatory neurotransmitter in the CENTRAL NERVOUS SYSTEM. Aluminum L-Glutamate,Glutamate,Potassium Glutamate,D-Glutamate,Glutamic Acid, (D)-Isomer,L-Glutamate,L-Glutamic Acid,Aluminum L Glutamate,D Glutamate,Glutamate, Potassium,L Glutamate,L Glutamic Acid,L-Glutamate, Aluminum

Related Publications

Francisco Ciruela, and Maricel Gómez-Soler, and Diego Guidolin, and Dasiel O Borroto-Escuela, and Luigi F Agnati, and Kjell Fuxe, and Víctor Fernández-Dueñas
November 2004, Journal of neurochemistry,
Francisco Ciruela, and Maricel Gómez-Soler, and Diego Guidolin, and Dasiel O Borroto-Escuela, and Luigi F Agnati, and Kjell Fuxe, and Víctor Fernández-Dueñas
January 2019, Neuroscience letters,
Francisco Ciruela, and Maricel Gómez-Soler, and Diego Guidolin, and Dasiel O Borroto-Escuela, and Luigi F Agnati, and Kjell Fuxe, and Víctor Fernández-Dueñas
September 2007, Physiology & behavior,
Francisco Ciruela, and Maricel Gómez-Soler, and Diego Guidolin, and Dasiel O Borroto-Escuela, and Luigi F Agnati, and Kjell Fuxe, and Víctor Fernández-Dueñas
August 2013, European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology,
Francisco Ciruela, and Maricel Gómez-Soler, and Diego Guidolin, and Dasiel O Borroto-Escuela, and Luigi F Agnati, and Kjell Fuxe, and Víctor Fernández-Dueñas
January 2004, Neurotoxicity research,
Francisco Ciruela, and Maricel Gómez-Soler, and Diego Guidolin, and Dasiel O Borroto-Escuela, and Luigi F Agnati, and Kjell Fuxe, and Víctor Fernández-Dueñas
January 1982, Progress in brain research,
Francisco Ciruela, and Maricel Gómez-Soler, and Diego Guidolin, and Dasiel O Borroto-Escuela, and Luigi F Agnati, and Kjell Fuxe, and Víctor Fernández-Dueñas
December 2021, European journal of pharmacology,
Francisco Ciruela, and Maricel Gómez-Soler, and Diego Guidolin, and Dasiel O Borroto-Escuela, and Luigi F Agnati, and Kjell Fuxe, and Víctor Fernández-Dueñas
September 2022, Molecular psychiatry,
Francisco Ciruela, and Maricel Gómez-Soler, and Diego Guidolin, and Dasiel O Borroto-Escuela, and Luigi F Agnati, and Kjell Fuxe, and Víctor Fernández-Dueñas
August 1988, The American journal of physiology,
Francisco Ciruela, and Maricel Gómez-Soler, and Diego Guidolin, and Dasiel O Borroto-Escuela, and Luigi F Agnati, and Kjell Fuxe, and Víctor Fernández-Dueñas
June 2009, Journal of neurochemistry,
Copied contents to your clipboard!